Hepatitis C in drug addicts: access and treatment compliance.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445 |
Resumo: | Currently, hepatitis C is a serious public health problem. It is estimated that there are 180 million people with chronic infection by hepatitis C virus (HCV) worldwide and that the prevalence of this infection in the Portuguese population ranges between 1 and 1.5%. In Portugal, there are neither up-to-date guidelines for treatment, nor recommendations for the diagnosis and management of patients with HCV and, in particular, for the endovenous drug users. The present article gathers consensus information regarding clinical practice and suggests some guidelines to the management and treatment accessibility of drug addicted patients with chronic infection by HCV, in Portugal. |
id |
RCAP_d2bb570fbc7177724dfed1a4b521a827 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/1445 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Hepatitis C in drug addicts: access and treatment compliance.Hepatite C em toxicodependentes: acompanhamento e acesso à terapêutica.Currently, hepatitis C is a serious public health problem. It is estimated that there are 180 million people with chronic infection by hepatitis C virus (HCV) worldwide and that the prevalence of this infection in the Portuguese population ranges between 1 and 1.5%. In Portugal, there are neither up-to-date guidelines for treatment, nor recommendations for the diagnosis and management of patients with HCV and, in particular, for the endovenous drug users. The present article gathers consensus information regarding clinical practice and suggests some guidelines to the management and treatment accessibility of drug addicted patients with chronic infection by HCV, in Portugal.Currently, hepatitis C is a serious public health problem. It is estimated that there are 180 million people with chronic infection by hepatitis C virus (HCV) worldwide and that the prevalence of this infection in the Portuguese population ranges between 1 and 1.5%. In Portugal, there are neither up-to-date guidelines for treatment, nor recommendations for the diagnosis and management of patients with HCV and, in particular, for the endovenous drug users. The present article gathers consensus information regarding clinical practice and suggests some guidelines to the management and treatment accessibility of drug addicted patients with chronic infection by HCV, in Portugal.Ordem dos Médicos2011-12-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445oai:ojs.www.actamedicaportuguesa.com:article/1445Acta Médica Portuguesa; Vol. 24 (2011): Suplemento 2; 483-92Acta Médica Portuguesa; Vol. 24 (2011): Suplemento 2; 483-921646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445/1033Sarmento E Castro, RuiValente, CristinaRamos, José PresaAlmeida, José RochaMarinho, Rui TatoBranco, TeresaAndrade, SofiaMacedo, Anainfo:eu-repo/semantics/openAccess2022-12-20T10:57:53Zoai:ojs.www.actamedicaportuguesa.com:article/1445Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:17:07.859677Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Hepatitis C in drug addicts: access and treatment compliance. Hepatite C em toxicodependentes: acompanhamento e acesso à terapêutica. |
title |
Hepatitis C in drug addicts: access and treatment compliance. |
spellingShingle |
Hepatitis C in drug addicts: access and treatment compliance. Sarmento E Castro, Rui |
title_short |
Hepatitis C in drug addicts: access and treatment compliance. |
title_full |
Hepatitis C in drug addicts: access and treatment compliance. |
title_fullStr |
Hepatitis C in drug addicts: access and treatment compliance. |
title_full_unstemmed |
Hepatitis C in drug addicts: access and treatment compliance. |
title_sort |
Hepatitis C in drug addicts: access and treatment compliance. |
author |
Sarmento E Castro, Rui |
author_facet |
Sarmento E Castro, Rui Valente, Cristina Ramos, José Presa Almeida, José Rocha Marinho, Rui Tato Branco, Teresa Andrade, Sofia Macedo, Ana |
author_role |
author |
author2 |
Valente, Cristina Ramos, José Presa Almeida, José Rocha Marinho, Rui Tato Branco, Teresa Andrade, Sofia Macedo, Ana |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Sarmento E Castro, Rui Valente, Cristina Ramos, José Presa Almeida, José Rocha Marinho, Rui Tato Branco, Teresa Andrade, Sofia Macedo, Ana |
description |
Currently, hepatitis C is a serious public health problem. It is estimated that there are 180 million people with chronic infection by hepatitis C virus (HCV) worldwide and that the prevalence of this infection in the Portuguese population ranges between 1 and 1.5%. In Portugal, there are neither up-to-date guidelines for treatment, nor recommendations for the diagnosis and management of patients with HCV and, in particular, for the endovenous drug users. The present article gathers consensus information regarding clinical practice and suggests some guidelines to the management and treatment accessibility of drug addicted patients with chronic infection by HCV, in Portugal. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-12-29 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445 oai:ojs.www.actamedicaportuguesa.com:article/1445 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/1445 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445/1033 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 24 (2011): Suplemento 2; 483-92 Acta Médica Portuguesa; Vol. 24 (2011): Suplemento 2; 483-92 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130624651427840 |